CJC-1295 + Ipamorelin
Price includes VAT. Shipping is calculated at checkout.
- Delivery within 1–2 business days
- Pickup at collection point available
- Discreetly packaged
Order before 14:00 for same-day shipping
For laboratory research use only. Not for human consumption.
What is the purity of CJC-1295 + Ipamorelin?
Both peptides are supplied at a HPLC-tested purity of 99%+ (HPLC, third-party tested). Each batch is independently analysed and a Certificate of Analysis (COA) is available on request.
How should this product be stored?
Store the lyophilized vial refrigerated at 2–8 °C and protected from light. After reconstitution, keep refrigerated and use within 2–4 weeks. For long-term storage of unreconstituted vials, -20 °C is recommended.
Is a Certificate of Analysis (COA) available?
Yes. A batch-specific third-party COA (HPLC purity, mass spectrometry) is available for every lot. Send us the batch number on your vial and we email the COA the same working day.
How is shipping within the EU handled?
We ship discreetly from the Netherlands with PostNL / MyParcel. Free shipping on orders over €250. Most EU destinations arrive within 2–5 working days with track & trace.
Is this product in stock and ready to ship?
Yes, this product is in stock in our Dutch warehouse. Orders placed before 16:00 on working days are shipped the same day.
Can this product be used for medical or human use?
CJC-1295 + Ipamorelin is sold strictly for laboratory research and research purposes only. It is not a medicine, food supplement or cosmetic and is not intended for human or veterinary use, diagnosis, or treatment.
Research Overview
CJC-1295 is a synthetic analog of growth hormone-releasing hormone that binds the GHRH receptor on pituitary somatotrophs to stimulate growth hormone synthesis and release, while Ipamorelin selectively activates the ghrelin receptor (GHS-R1a) to trigger GH pulses with minimal effect on cortisol, prolactin or ACTH. Used together, the two peptides act on distinct but complementary pathways, producing a synergistic increase in GH pulse amplitude in preclinical models. The combination is studied in research contexts examining GH/IGF-1 axis physiology, pituitary secretory dynamics and downstream metabolic signaling.
Primary Research Areas
Synergistic GH/IGF-1 axis stimulation (dual-receptor mechanism)
Pituitary somatotroph secretory dynamics and GH pulsatility
GHS-R1a (ghrelin receptor) selectivity and off-target hormone studies (cortisol/prolactin)
Body composition, lean mass and metabolic signaling models
For Research Use Only
This product is intended solely for in-vitro research and laboratory use. Not intended for human consumption, diagnostic or therapeutic purposes.
Research Relevance
Purity: 99%
Form: Lyophilized powder in glass vial
CJC-1295 + Ipamorelin research-grade lyophilized peptide blend powder in a glass vial. A GHRH analog paired with a selective GHS-R1a agonist, studied in preclinical models for synergistic GH/IGF-1 axis and pituitary secretory dynamics research. Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Research Relevance
- Purity: 99%, Form
- CJC-1295 + Ipamorelin research peptide blend, lyophilized powder in a glass vial. A GHRH analog paired with a selective GHS-R1a agonist, studied in preclinical models for synergistic GH/IGF-1 axis stimulation and pituitary secretory dynamics research. Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
